Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Trisodium edetate 1g/5ml solution for injection ampoules 6 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Limclair 1g/5ml solution for injection ampoules (B & S Durbin) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naloxone 800micrograms/2ml solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet naloxone 800micrograms/2ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 500micrograms/5ml solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet atropine 500micrograms/5ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1mg/10ml solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet atropine 1mg/10ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/30ml solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet atropine 3mg/30ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Metaraminol 10mg/1ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aramine 10mg/1ml solution for injection ampoules (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Foscarnet sodium 6g/250ml solution for injection bottles 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Foscavir 6g/250ml solution for injection bottles (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Marcain 0.25% with Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Levofloxacin 500mg/100ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tavanic 500mg/100ml solution for injection vials (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Marcain 0.5% with Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 5mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cidomycin Intrathecal 5mg/1ml solution for injection ampoules (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for injection 10ml ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for injection 10ml ampoules (Unichem Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zidovudine 200mg/20ml solution for injection vials 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mivacurium chloride 20mg/10ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Retrovir I.V. for Infusion 20ml vials (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mivacron 20mg/10ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mivacurium chloride 10mg/5ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mivacron 10mg/5ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bretylium tosilate 500mg/10ml solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bretylate 500mg/10ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bretylium tosilate 100mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bretylate 100mg/2ml solution for injection ampoules (GlaxoSmithKline) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Docetaxel 20mg/0.5ml solution for injection vials and diluent 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxotere 20mg/0.5ml solution for injection vials and diluent (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Procainamide 1g/10ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pronestyl 1g/10ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paclitaxel 30mg/5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxol 30mg/5ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paclitaxel 100mg/16.7ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxol 100mg/16.7ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Docetaxel 80mg/2ml solution for injection vials and diluent 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxotere 80mg/2ml solution for injection vials and diluent (Aventis Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 2,500units/0.5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 2,500units/0.5ml solution for injection vials (Medeus Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 5,000units/1ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 5,000units/1ml solution for injection vials (Medeus Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Botulinum toxin type B 10,000units/2ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 10,000units/2ml solution for injection vials (Medeus Pharma) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium levofolinate 25mg/2.5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Isovorin 25mg/2.5ml solution for injection vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 150mg/15ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 150mg/15ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 450mg/45ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 450mg/45ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxycodone 10mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
OxyNorm 10mg/1ml solution for injection ampoules (Napp Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 450mg/45ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 350mg/35ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 150mg/15ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxycodone 20mg/2ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
OxyNorm 20mg/2ml solution for injection ampoules (Napp Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 350mg/35ml solution for injection vials (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lederfolin 350mg/35ml solution for injection vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cidofovir 375mg/5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Vistide 375mg/5ml solution for infusion vials (Gilead Sciences Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methoxamine 20mg/1ml solution for injection ampoules 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Vasoxine 20mg/1ml solution for injection ampoules (Glaxo Wellcome UK Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 50mg/5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 50mg/5ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 50mg/5ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 600mg/60ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 600mg/60ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemophilus type b conjugate vaccine solution for injection 0.5ml vials 10 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
HibTITER vaccine solution for injection 0.5ml vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 600mg/60ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Milrinone 10mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Primacor 10mg/10ml solution for injection ampoules (Sanofi-Synthelabo Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glyceryl trinitrate 10mg/10ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nitrocine 10mg/10ml solution for infusion ampoules (Forum Health Products Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Laronidase 500units/5ml solution for injection vials 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aldurazyme 500units/5ml concentrate for solution for infusion vials (Sanofi Genzyme) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Etamsylate 250mg/2ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dicynene 250mg/2ml solution for injection ampoules (Sanofi-Synthelabo Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fosfestrol 300mg/5ml solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Honvan 300mg/5ml solution for injection ampoules (ASTA Medica Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dicobalt edetate 300mg/20ml solution for injection ampoules 6 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|